Julie Jones

1.6k citations
25 papers · 1.0k indexed · h-index 15
Topics
Breast Cancer Treatment Studies (5 papers)Cancer therapeutics and mechanisms (4 papers)DNA Repair Mechanisms (3 papers)

In The Last Decade

Julie Jones

25 papers receiving 964 citations

Peers

Julie Jones
Comparison fields: 5 of 108
  • Molecular Biology 316
  • Oncology 243
  • Cancer Research 190
  • Pulmonary and Respiratory Medicine 148
  • Pathology and Forensic Medicine 130
Replace Melvin Toh with:
Melvin Toh United States
Hongyan Qi China
Veena Coothankandaswamy United States
William K. Chan United States
Appu Rathinavelu United States
Maryam Akbarzadeh Iran
Lijun Sun United States
Martijn Rooseboom Netherlands
Yi‐Ru Chen Taiwan
Wolfgang A. Schmalix Germany
Julie Jones relative to Melvin Toh United States Melvin Toh's profile →
Citations per field
00.5×1.5×1.8×
Melvin Toh · 1×
Citations per year

Countries citing papers authored by Julie Jones

Since Specialization
Citations

This map shows the geographic impact of Julie Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Jones more than expected).

Fields of papers citing papers by Julie Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Jones. The network helps show where Julie Jones may publish in the future.

Co-authorship network of co-authors of Julie Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Jones. A scholar is included among the top collaborators of Julie Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Jones. Julie Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 1
4 147
5 121
6 3
7 26
8 75
9 6
10 20
11 16
12 67
13 2
14 34
15 174
16 36
17
Preclinical anticancer activity of cryptophycin-8.
25
18 97
19 83
20 29

About Julie Jones

Julie Jones is a scholar working on Horticulture, Toxicology and Cancer Research, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Cancer therapeutics and mechanisms (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Horticulture (54 citations), Pharmaceutical Science (117 citations) and Cancer Research (190 citations). Julie Jones has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Sujatha Rajaram, Grace J. Lee, Thomas H. Corbett, Barbara L. Smith, Michele A. Gadd, Kevin S. Hughes, Michelle C. Specht, Jerry L. McLaughlin, Nicholas H. Oberlies and James G. Roddick. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026